Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q2 2017 call → NOWe need to determine if management's forward account is substantially about counterparties' own growth/ramp/expansion, with the company already inside that growth, and the trajectory early and large relative to the company. Let's examine the transcript. Management discusses various programs: 747-8, G650, Global 7000, Embraer E2, etc. They talk about their own performance, restructuring, cost savings, cash flow. They also mention customer programs: e.g., Bombardier's Global 7000 development, Embraer E2, Gulfstream G650, etc. But the question is: does management narrate what counterparties are themselves doing and scaling, such that the company's own volume is presented as a consequence of those parties' trajectories? Look for specific instances. For example, on Global 7000: "our focus remains helping Bombardier to get the test aircraft in the air, complete development and the remaining test articles, and prepare for the transition to production given the robust demand for the platform. As Bombardier recently announced, they are very close to first flight, ground test results have been positive, and development is beginning to close. Triumph continues to deliver test wings to Bombardier's final assembly line and has started assembly of the first production wing." This describes Bombardier's progress and Triumph's role. But is this about Bombardier's own scaling? It's about development and transition to production. The company is already supplying test wings and starting production wing. The trajectory is early (first production wing). However, is this a substantial part of the forward account? The call covers many topics: restructuring, cost savings, cash flow, new business wins, etc. The forward guidance is reaffirmed, with revenue adjusted downward due to slowing demand on legacy programs. The management's forward account seems to be about their own transformation, cost reduction, and program execution. They mention customer programs but not as a coherent posture where the company's future is driven by counterparties' expansion. They also discuss new business wins, pipeline, etc.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.